Global

Biochemistry Experts

John R. Silvius

Professor
Biochemistry
McGill University
Canada

Biography

1979 - PhD, University of Alberta

Research Interest

Membrane-associated signaling proteins typically function correctly only when targeted to a specific cellular membrane compartment, and often only when targeted to specific domains within this membrane compartment. Our research interests are focused on understanding two important aspects of the targeting, and hence the function, of proteins involved in signal transduction at the plasma membrane: Understanding the organization and function of the specialized membrane microdomains known as 'lipid rafts'. These domains, found within the plasma and certain other membranes of mammalian cells, exhibit a physical organization and composition distinct from those of non-'raft' regions of the membrane and serve distinct functions as well, notably in membrane signal transduction and in sorting of membrane proteins (and lipids) during intracellular membrane trafficking. We are currently working to define better the structural features of membrane-associated molecules that govern their ability to associate with rafts, and to assess how varying the organization and distribution of rafts modulates signal transduction at the plasma membrane in mammalian cells. Elucidating the mechanisms of targeting of lipidated signaling proteins to their correct subcellular destinations. Our current interests in this area are focused on two classes of protooncogenic lipid-modified signaling proteins: the farnesylated ras small G-proteins and N/S-acylated proteins such as the src-homologous intracellular tyrosine kinases. Our objectives are to understand how these proteins are targeted to their correct membrane (and submembrane) destinations, and to identify enzymes or receptors involved in their targeting as potential sites for pharmacological intervention (e.g., to block the oncogenic actions of mutationally activated forms of these proteins).

Publications

  • Obatoclax is a direct and potent antagonist of membrane-restricted Mcl-1 and is synthetic lethal with treatment that induces Bim. Nguyen M, Cencic R, Ertel F, Bernier C, Pelletier J, Roulston A, Silvius JR, Shore GC.

  • A Novel "Prebinding" Strategy Dramatically Enhances Sortase-Mediated Coupling of Proteins to Liposomes. Silvius JR, Leventis R.

  • Incorporation of Artificial Lipid-Anchored Proteins into Cultured Mammalian Cells. Leventis R, Silvius JR.

Global Experts from Canada

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America